US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.130
  • +0.010+0.07%
Close May 15 16:00 ET
  • 15.130
  • 0.0000.00%
Post 16:00 ET
219.87MMarket Cap-189125P/E (TTM)

Merrimack Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-2.90%18.88M
-2.90%18.88M
44.40%18.9M
42.03%18.97M
35.73%19.4M
36.87%19.44M
36.87%19.44M
-10.08%13.09M
-10.42%13.36M
2.91%14.29M
-Cash and cash equivalents
-69.19%5.99M
-69.19%5.99M
-53.53%6.08M
-24.14%10.13M
35.73%19.4M
36.87%19.44M
36.87%19.44M
-10.08%13.09M
-10.42%13.36M
2.91%14.29M
-Short-term investments
--12.89M
--12.89M
--12.82M
--8.84M
----
--0
--0
----
----
----
Other current assets
-20.57%309K
-20.57%309K
-27.37%390K
-31.30%474K
-29.06%227K
-18.96%389K
-18.96%389K
-15.57%537K
-14.29%690K
-86.44%320K
Total current assets
-3.25%19.18M
-3.25%19.18M
41.58%19.29M
38.43%19.44M
34.31%19.63M
35.04%19.83M
35.04%19.83M
-10.31%13.63M
-10.62%14.05M
-10.07%14.61M
Non current assets
Other non current assets
-50.00%4K
-50.00%4K
-44.44%5K
-40.00%6K
-72.00%7K
-87.88%8K
-87.88%8K
-91.67%9K
-93.29%10K
-86.91%25K
Total non current assets
-50.00%4K
-50.00%4K
-44.44%5K
-40.00%6K
-72.00%7K
-87.88%8K
-87.88%8K
-91.67%9K
-93.29%10K
-86.91%25K
Total assets
-3.27%19.19M
-3.27%19.19M
41.52%19.3M
38.37%19.45M
34.13%19.64M
34.49%19.84M
34.49%19.84M
-10.88%13.64M
-11.40%14.06M
-10.96%14.64M
Liabilities
Current liabilities
Payables
-60.64%74K
-60.64%74K
65.67%111K
-4.76%80K
-49.72%89K
56.67%188K
56.67%188K
-35.58%67K
-51.45%84K
63.89%177K
-accounts payable
-60.64%74K
-60.64%74K
65.67%111K
-4.76%80K
-49.72%89K
56.67%188K
56.67%188K
-35.58%67K
-51.45%84K
63.89%177K
Current accrued expenses
-16.19%176K
-16.19%176K
0.53%191K
-15.66%140K
-6.63%183K
-16.33%210K
-16.33%210K
-20.17%190K
-35.66%166K
-16.60%196K
Other current liabilities
0.00%191K
0.00%191K
0.00%191K
0.00%191K
0.00%191K
0.00%191K
0.00%191K
-43.99%191K
-43.99%191K
-43.99%191K
Current liabilities
-25.13%441K
-25.13%441K
10.04%493K
-6.80%411K
-17.91%463K
4.80%589K
4.80%589K
-34.41%448K
-42.88%441K
-17.54%564K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-25.13%441K
-25.13%441K
10.04%493K
-6.80%411K
-17.91%463K
4.80%589K
4.80%589K
-34.41%448K
-42.88%441K
-17.54%564K
Shareholders'equity
Share capital
0.07%1.34M
0.07%1.34M
0.67%1.34M
0.67%1.34M
0.67%1.34M
0.60%1.34M
0.60%1.34M
0.00%1.33M
0.00%1.33M
0.00%1.33M
-common stock
0.07%1.34M
0.07%1.34M
0.67%1.34M
0.67%1.34M
0.67%1.34M
0.60%1.34M
0.60%1.34M
0.00%1.33M
0.00%1.33M
0.00%1.33M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-0.22%-548.82M
-0.22%-548.82M
-0.26%-548.58M
-0.29%-548.3M
-0.31%-547.91M
-0.28%-547.64M
-0.28%-547.64M
-0.28%-547.14M
-0.30%-546.7M
-0.35%-546.22M
Paid-in capital
0.12%566.22M
0.12%566.22M
1.26%566.04M
1.25%565.99M
1.21%565.74M
1.18%565.54M
1.18%565.54M
0.02%559M
0.02%558.98M
0.04%558.97M
Total stockholders'equity
-2.60%18.75M
-2.60%18.75M
42.59%18.81M
39.83%19.04M
36.21%19.17M
35.67%19.25M
35.67%19.25M
-9.78%13.19M
-9.79%13.61M
-10.67%14.08M
Total equity
-2.60%18.75M
-2.60%18.75M
42.59%18.81M
39.83%19.04M
36.21%19.17M
35.67%19.25M
35.67%19.25M
-9.78%13.19M
-9.79%13.61M
-10.67%14.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -2.90%18.88M-2.90%18.88M44.40%18.9M42.03%18.97M35.73%19.4M36.87%19.44M36.87%19.44M-10.08%13.09M-10.42%13.36M2.91%14.29M
-Cash and cash equivalents -69.19%5.99M-69.19%5.99M-53.53%6.08M-24.14%10.13M35.73%19.4M36.87%19.44M36.87%19.44M-10.08%13.09M-10.42%13.36M2.91%14.29M
-Short-term investments --12.89M--12.89M--12.82M--8.84M------0--0------------
Other current assets -20.57%309K-20.57%309K-27.37%390K-31.30%474K-29.06%227K-18.96%389K-18.96%389K-15.57%537K-14.29%690K-86.44%320K
Total current assets -3.25%19.18M-3.25%19.18M41.58%19.29M38.43%19.44M34.31%19.63M35.04%19.83M35.04%19.83M-10.31%13.63M-10.62%14.05M-10.07%14.61M
Non current assets
Other non current assets -50.00%4K-50.00%4K-44.44%5K-40.00%6K-72.00%7K-87.88%8K-87.88%8K-91.67%9K-93.29%10K-86.91%25K
Total non current assets -50.00%4K-50.00%4K-44.44%5K-40.00%6K-72.00%7K-87.88%8K-87.88%8K-91.67%9K-93.29%10K-86.91%25K
Total assets -3.27%19.19M-3.27%19.19M41.52%19.3M38.37%19.45M34.13%19.64M34.49%19.84M34.49%19.84M-10.88%13.64M-11.40%14.06M-10.96%14.64M
Liabilities
Current liabilities
Payables -60.64%74K-60.64%74K65.67%111K-4.76%80K-49.72%89K56.67%188K56.67%188K-35.58%67K-51.45%84K63.89%177K
-accounts payable -60.64%74K-60.64%74K65.67%111K-4.76%80K-49.72%89K56.67%188K56.67%188K-35.58%67K-51.45%84K63.89%177K
Current accrued expenses -16.19%176K-16.19%176K0.53%191K-15.66%140K-6.63%183K-16.33%210K-16.33%210K-20.17%190K-35.66%166K-16.60%196K
Other current liabilities 0.00%191K0.00%191K0.00%191K0.00%191K0.00%191K0.00%191K0.00%191K-43.99%191K-43.99%191K-43.99%191K
Current liabilities -25.13%441K-25.13%441K10.04%493K-6.80%411K-17.91%463K4.80%589K4.80%589K-34.41%448K-42.88%441K-17.54%564K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -25.13%441K-25.13%441K10.04%493K-6.80%411K-17.91%463K4.80%589K4.80%589K-34.41%448K-42.88%441K-17.54%564K
Shareholders'equity
Share capital 0.07%1.34M0.07%1.34M0.67%1.34M0.67%1.34M0.67%1.34M0.60%1.34M0.60%1.34M0.00%1.33M0.00%1.33M0.00%1.33M
-common stock 0.07%1.34M0.07%1.34M0.67%1.34M0.67%1.34M0.67%1.34M0.60%1.34M0.60%1.34M0.00%1.33M0.00%1.33M0.00%1.33M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -0.22%-548.82M-0.22%-548.82M-0.26%-548.58M-0.29%-548.3M-0.31%-547.91M-0.28%-547.64M-0.28%-547.64M-0.28%-547.14M-0.30%-546.7M-0.35%-546.22M
Paid-in capital 0.12%566.22M0.12%566.22M1.26%566.04M1.25%565.99M1.21%565.74M1.18%565.54M1.18%565.54M0.02%559M0.02%558.98M0.04%558.97M
Total stockholders'equity -2.60%18.75M-2.60%18.75M42.59%18.81M39.83%19.04M36.21%19.17M35.67%19.25M35.67%19.25M-9.78%13.19M-9.79%13.61M-10.67%14.08M
Total equity -2.60%18.75M-2.60%18.75M42.59%18.81M39.83%19.04M36.21%19.17M35.67%19.25M35.67%19.25M-9.78%13.19M-9.79%13.61M-10.67%14.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg